...
首页> 外文期刊>Lasers in surgery and medicine >Intravascular low-power laser irradiation after coronary stenting: long-term follow-up.
【24h】

Intravascular low-power laser irradiation after coronary stenting: long-term follow-up.

机译:血管内低功率激光照射后冠状动脉支架:长期随访。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: A high restenosis rate remains a limiting factor for percutaneous transluminal coronary angioplasty and stenting. The objective of this study was to evaluate the effect of intravascular red laser therapy (IRLT) on restenosis after stenting procedures in de novo lesions. STUDY DESIGN/MATERIALS AND METHODS: A total of 68 consecutive patients were treated with IRLT in conjunction with coronary stenting procedures. Mean lesion length was 16.5 +/- 2.4 mm. Reference vessel diameter (RVD) and pre-minimal lumen diameter (MLD) were 2.90 +/- 0.15 mm and 1.12 +/- 0.26 mm, respectively. RESULTS: After treatment, MLD was 2.76 +/- 0.32 mm with no procedural complications or in-hospital adverse events. Angiographic follow-up (n = 61) revealed restenosis in nine patients (14.7%) with rate by artery size of > 3 mm (n = 21) 0%; 2.5--3.0 mm (n = 28) 14.2%; and < 2.5 mm (n = 12) 41.6%. CONCLUSION: Intravascular red light therapy is safe, feasible, and reduces expected restenosis rate after coronary stenting. Copyright 2001 Wiley-Liss, Inc.
机译:背景和目的:较高的再狭窄率经皮的仍然是一个限制因素冠状血管成形术和支架植入腔间。本研究的目的是评估影响血管内红色激光疗法(IRLT)在支架植入后再狭窄过程在德新生病变。共有68个连续的患者治疗与IRLT结合冠状支架程序。毫米。参考血管直径中心(RVD)pre-minimal腔直径(MLD)是2.90 + / -0.15毫米和1.12 + / - 0.26毫米,分别。结果:治疗后,MLD是2.76 + / - 0.32没有程序上的并发症或毫米住院不良事件。后续(n = 61)显示再狭窄9患者(14.7%)率的动脉大小> 3毫米(n = 21) 0%;2.5毫米(n = 12) 41.6%。红光治疗是安全、可行的,并减少冠状动脉支架再狭窄率。版权2001 Wiley-Liss公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号